Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.

Kinon, B J; Basson, B R; Gilmore, J A; Malcolm, S; Stauffer, V L

Kinon, B J; Basson, B R; Gilmore, J A; Malcolm, S; Stauffer, V L.

Affiliation

Kinon BJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Ind 46285, USA.

J Clin Psychiatry ; 61(11): 833-40, 2000 Nov.

Article in En | MEDLINE | ID: mdl-11105736

Subject(s)

Antipsychotic Agents/therapeutic use; Pirenzepine/analogs & derivatives; Pirenzepine/therapeutic use; Psychotic Disorders/drug therapy; Risperidone/therapeutic use; Schizophrenia/drug therapy; Adult; Ambulatory Care; Antipsychotic Agents/administration & dosage; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine/administration & dosage; Placebos; Psychotic Disorders/psychology; Risperidone/administration & dosage; Schizophrenic Psychology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents / Pirenzepine / Risperidone Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychiatry Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links